MCID: NLD001
MIFTS: 56

Nail Disease malady

Categories: Genetic diseases, Skin diseases, Rare diseases

Aliases & Classifications for Nail Disease

About this section

Summaries for Nail Disease

About this section
MedlinePlus:37 Your toenails and fingernails protect the tissues of your toes and fingers. they are made up of layers of a hardened protein called keratin, which is also in your hair and skin. the health of your nails can be a clue to your overall health. healthy nails are usually smooth and consistent in color. specific types of nail discoloration and changes in growth rate can be signs of lung, heart, kidney, and liver diseases, as well as diabetes and anemia. white spots and vertical ridges are harmless. nail problems that sometimes require treatment include bacterial and fungal infections ingrown nails tumors warts keeping your nails clean, dry, and trimmed can help you avoid some problems. do not remove the cuticle, which can cause infection.

MalaCards based summary: Nail Disease, also known as nail diseases, is related to paronychia and eversion of lacrimal punctum, and has symptoms including exanthema, pruritus and skin manifestations. An important gene associated with Nail Disease is FZD6 (Frizzled Class Receptor 6), and among its related pathways are Regulation of FZD by ubiquitination and a6b1 and a6b4 Integrin signaling. Affiliated tissues include nail, skin and kidney, and related mouse phenotype integument.

Disease Ontology:11 An integumentary system disease that is located in nail.

Wikipedia:70 Nail diseases are diseases or deformities of the nails. Although the nail is a structure produced by the... more...

Related Diseases for Nail Disease

About this section

Diseases in the Nail Disease family:

Nail Disorder, Nonsyndromic Congenital, 3, Nail Disorder, Nonsyndromic Congenital, 10,
Nail Disorder, Nonsyndromic Congenital, 7 Nail Disorder, Nonsyndromic Congenital, 9
Nail Disorder, Nonsyndromic Congenital, 1 Nonsyndromic Congenital Nail Disorder 2
Nonsyndromic Congenital Nail Disorder 5 Nonsyndromic Congenital Nail Disorder 6

Diseases related to Nail Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 70)
idRelated DiseaseScoreTop Affiliating Genes
1paronychia10.7
2eversion of lacrimal punctum10.2EGFR, HRAS
3tic disorder10.2EGFR, HRAS
4psoriatic arthritis10.0
5arthritis10.0
63q26q27 microdeletion syndrome9.9EGFR, KRAS
7vagina sarcoma9.9HRAS, KRAS
8glomerulosclerosis9.9HRAS, KRAS
9pseudounicornuate uterus9.9EGFR, KRAS
10epidermal nevus, somatic9.9HRAS, KRAS
11schimmelpenning-feuerstein-mims syndrome, somatic mosaic9.9HRAS, KRAS
12seminal vesicle chronic gonorrhea9.9HRAS, KRAS
13brown-vialetto-van laere syndrome 19.9ESCO1, RSPO4, ZNF519
14psoriasis9.9
15ureter adenocarcinoma9.9HRAS, KRAS
16spindle epithelial tumor with thymus-like differentiation tumor9.9HRAS, KRAS
17uterine ligament serous adenocarcinoma9.9HRAS, KRAS
18appendix mucinous cystadenocarcinoma9.9HRAS, KRAS
19tabes dorsalis9.9HRAS, KRAS
20acanthoma9.9HRAS, KRAS
21adenofibroma9.9HRAS, KRAS
22dermatosis papulosa nigra9.9HRAS, KRAS
23classic pulmonary blastoma9.9EGFR, KRAS
24migraine with aura9.8HRAS, KRAS
25ovarian serous adenofibroma9.8HRAS, KRAS
26advanced sleep phase syndrome9.8HRAS, KRAS
27papilloma9.8HRAS, KRAS
28rete testis neoplasm9.8HRAS, KRAS
29vibratory urticaria9.8HRAS, KRAS
30gastric adenocarcinoma9.8HRAS, KRAS
31epilepsy with generalized tonic-clonic seizures9.8HRAS, KRAS
32critical congenital heart disease9.8HRAS, KRAS
33nail disorder, nonsyndromic congenital, 10,9.8
34radioulnar synostosis9.8HRAS, KRAS
35pyoderma9.8HRAS, KRAS
36intrahepatic cholangiocarcinoma9.7HRAS, KRAS
37breast scirrhous carcinoma9.7HRAS, KRAS
38growth restriction, severe, with distinctive facies9.7HRAS, KRAS
39hemangioma of lung9.7HRAS, KRAS
40gastrointestinal neuroendocrine tumor9.6HRAS, KRAS
41enthesopathy9.6
42submucosal invasive colon adenocarcinoma9.6EGFR, KRAS
43periapical granuloma9.5HRAS, KRAS
44leopard syndrome 19.5HRAS, KRAS
45gonococcal spondylitis9.5EGFR, HRAS, KRAS
46trachea adenoid cystic carcinoma9.5EGFR, HRAS, KRAS
47breast papillary carcinoma9.5EGFR, HRAS, KRAS
48adenosquamous carcinoma9.5EGFR, HRAS, KRAS
49early congenital syphilis9.5EGFR, HRAS, KRAS
50dental caries9.5EGFR, HRAS, KRAS

Graphical network of the top 20 diseases related to Nail Disease:



Diseases related to nail disease

Symptoms for Nail Disease

About this section

UMLS symptoms related to Nail Disease:


exanthema, pruritus, skin manifestations, koilonychia, beau's lines, clubbing of nail, onychomadesis, thin nails, nail symptom/complaint, nail discomfort, nail bed hemorrhage, nail bed tenderness, abnormal nail growth, yellow nails, symptoms of the nails of toes

Drugs & Therapeutics for Nail Disease

About this section

Drugs for Nail Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 225)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Phenolapproved, experimentalPhase 445108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Cepastat lozenges
Cuticura pain relieving ointment
Fenol
Fenolo
Fenosmolin
Fenosmoline
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Liquefied phenol
Liquid phenol
Liquified phenol
 
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Synthetic phenol
Tea polyphenol
2
Terbinafineapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2, Phase 13391161-71-65402, 1549008
Synonyms:
(2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)-2-hepten-4-yn-1-amine
(2E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine
(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine
(E)-N-(6,6-dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride
(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine
(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine
91161-71-6
AC-12049
AC1LU7MZ
AKOS001451917
BIDD:GT0825
BRN 4256376
Bramazil
C08079
CHEBI:156831
CHEMBL822
CID1549008
D02375
DB00857
HMS2089B20
LS-94722
Lamasil
Lamasil (TN)
 
Lamisil
Lamisil AT
Lamisil Oral
Lamisil Tablet
Lamisil, Terbinex, Corbinal, Zabel, Terbinafine
MolPort-002-507-761
MolPort-004-637-919
NCGC00159346-02
NCGC00159346-03
S1725_Selleck
SF 86-327
SF-86-327
STK802069
STOCK5S-43972
TerbiFoam
Terbifoam
Terbina
Terbinafina
Terbinafine (USAN/INN)
Terbinafine HCl
Terbinafine [USAN:BAN:INN]
Terbinafine hydrochloride
Terbinafine, SF-86-327, Lamisil, TBNF
Terbinafinum
Ternbinafine HCl
UNII-G7RIW8S0XP
terbinafine
3
Ciclopiroxapproved, investigationalPhase 4, Phase 3, Phase 21429342-05-02749
Synonyms:
(6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone)
29342-05-0
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
6-Cyclohexyl-1-hydroxy-4-methyl-2-(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridinone
6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
AC-13011
AC1L1EDN
BIDD:GT0080
BPBio1_000641
BSPBio_000581
BSPBio_002041
C12H17NO2
CHEBI:453011
CHEMBL1413
CICLOPIROX
CID2749
Ciclopirox (USP/INN)
Ciclopirox Olamin
Ciclopirox [USAN:BAN:INN]
Ciclopirox gel
Ciclopirox-Olamin
Ciclopiroxolamine
Ciclopiroxum
Ciclopiroxum [INN-Latin]
D03488
DB01188
Dafnegin-CSC
EINECS 249-577-2
 
HOE 296b
HOE-296
HOE-296b
I06-0862
KBio3_001261
KBioGR_000816
LS-174247
Loprox
Loprox (TN)
Loprox Gel
Loprox Shampoo
Loprox cream
NCGC00178850-01
NCGC00178850-02
Penlac
Penlac (TN)
Penlac nail lacquer
Prestwick0_000541
Prestwick1_000541
Prestwick2_000541
Prestwick3_000541
SPBio_000252
SPBio_002502
Spectrum2_000146
Spectrum3_000351
Spectrum4_000288
Spectrum5_000747
Stieprox
TL8002303
Terit
UNII-19W019ZDRJ
cyclopirox
cyclopyroxolamine
4
BifonazoleapprovedPhase 4, Phase 3460628-96-82378
Synonyms:
(+-)-1-(p,alpha-Diphenylbenzyl)imidazole
(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole
1-((4-Biphenylyl)phenylmethyl)-1H-imidazole
1-(alpha-(4-Biphenylyl)benzyl)imidazole
1-(p,alpha-Diphenylbenzyl)imidazole
1-[4,alpha-Diphenylbenzyl]-imidazole
1-[biphenyl-4-yl(phenyl)methyl]-1H-imidazole
1-[phenyl-(4-phenylphenyl)methyl]imidazole
5-23-04-00292 (Beilstein Handbook Reference)
60628-96-8
AC-15414
AC1L1DJN
Amycor
Azolmen
BAY H 4502
BRD-A94543220-001-02-3
BRN 0618427
BSPBio_003570
Bay H-4502
Bay h 4502
Bay-h-4502
Bayer brand of bifonazole
Bifokey
Bifomyk
Bifon
Bifonazol
Bifonazol [INN-Spanish]
Bifonazol [inn-spanish]
Bifonazole (JP15/USAN/INN)
Bifonazole [USAN:BAN:INN:JAN]
Bifonazolum
Bifonazolum [INN-Latin]
Bifonazolum [inn-latin]
Bio-0008
Bioglan brand of bifonazole
C036596
C22H18N2
CHEBI:116973
 
CHEMBL277535
CID2378
CPD000058970
Canesten Extra Bifonazol
Canesten brand of bifonazole
D01775
DB04794
Dermapharm brand of bifonazole
EINECS 262-336-6
HMS1922B18
HMS2051F04
HMS2090K13
HMS2093B09
I01-2098
Inkeysa brand of bifonazole
Juventus brand of bifonazole
KBio3_002922
LS-78073
MLS000028576
MLS000759537
MLS001074074
Merck Lipha Sante brand of bifonazole
MolPort-003-666-632
Moldina
Mycospor
Mycospor (TN)
NCGC00089815-02
NCGC00089815-03
NCGC00089815-04
SAM001246775
SMR000058970
SPBio_000129
SPECTRUM1505309
STK618771
Spectrum2_000035
Spectrum3_001970
TL8003842
Trifonazole
VU0239694-7
bifonazole
5
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
6
EthanolapprovedPhase 4, Phase 3204364-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
7
Chlorhexidineapproved, vet_approvedPhase 447255-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
8
EzogabineapprovedPhase 4, Phase 327150812-12-7121892
Synonyms:
150812-12-7
AC-6908
AC1L3TLD
ADD-230001
C101866
C13826
C16H18FN3O2
CHEBI:161945
CHEMBL41355
CID121892
Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester
D 20443
D 23129
D-20443
D-23129
EZG
Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate
Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
 
Ezogabine
FT-0080801
GKE-841
I06-0810
KE-0201
LS-48932
MolPort-003-850-148
N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
Potiga
RTG
Retigabine
Retigabine [USAN]
TL80090034
Trobalt
UNII-12G01I6BBU
ZINC00016154
[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate
ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride
ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
nchembio874-comp3
9
LenograstimapprovedPhase 41202135968-09-1
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
 
Granulocyte colony stimulating factor 3 (CHO cell derived)
Granulocyte colony-stimulating factor lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
10
Apremilastapproved, investigationalPhase 4, Phase 264608141-41-911561674
Synonyms:
Apremilast
Apremilast (USAN)
Apremilastum
Aprémilast
CC-10004
 
CHEBI:558773
CHEMBL514800
CID11561674
D08860
N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
11
Etanerceptapproved, investigationalPhase 4, Phase 3397185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
12
AdalimumabapprovedPhase 4, Phase 3478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
13
AcitretinapprovedPhase 43055079-83-96437841, 5284513
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
(all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
13-cis-Acitretin
44707_FLUKA
44707_SIGMA
54757-46-9
55079-83-9
9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
AC-4702
AC1NR4LJ
AC1Q5T6I
Acetretin
Acitretin
Acitretin (USAN/INN)
Acitretin [USAN:INN:BAN]
Acitretina
Acitretina [Spanish]
Acitretine
Acitretine [French]
Acitretinum
Acitretinum [Latin]
BIDD:GT0617
Bio-0002
CCRIS 5534
CHEBI:50173
CHEMBL1131
CID5284513
CPD000499573
 
D02754
EINECS 259-474-4
Etretin
FT-0082892
HSDB 7187
Isoacitretin
Isoetretin
LS-96920
MLS001076667
MolPort-003-925-892
NCGC00163127-01
NCGC00163127-02
Neotigason
Retinoid etretin
Ro 10-1670
Ro 10-1670/000
Ro 13-7652
Ro-10-1670
Ro-10-1670/000
Ro-13-7652
S1368_Selleck
SAM002589973
SBB064171
SMR000499573
Soriatane
Soriatane (TN)
Soriatane, Acitretin
Spectrum5_002065
TMMP
U0279
UNII-LCH760E9T7
all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid
all-trans-Acitretin
14
BenzocaineapprovedPhase 4, Phase 318921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
15
Ustekinumabapproved, investigationalPhase 4, Phase 382815610-63-0
Synonyms:
 
Stelera
16
Itraconazoleapproved, investigationalPhase 4, Phase 3, Phase 214784625-61-655283
Synonyms:
(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one
(+/-)-1-[( R *)- sec -butyl]-4-[ p -[4-[ p -[[(2 R *,4 S *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-(DELTA) 2 1,2,4-triazolin-5-one mixture with (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4- [ p -[[(2 S *,4 R *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl] phenyl]-(DELTA) 2 -1,2,4-triazolin-5-one
(1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one
2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)
4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
84604-65-9
84625-61-6
AC-542
AC1L1GQ5
AC1L1IRU
AC1OCEL7
AC1Q6EZ3
AKOS000280875
Ambap84625-61-6
BIDD:GT0796
BRN 6042047
C35H38Cl2N8O4
CHEBI:6076
CHEMBL22587
CHEMBL882
CID3793
CID55283
CID6917738
CID9961741
CPD000058959
Canadiol
D00350
DB01167
EINECS 283-347-2
FT-0082511
HMS2051K14
HMS2090M20
Hyphanox
I01-1043
I0732
ITC
ITCZ
ITZ
Intraconazole
 
Itraconazol
Itraconazol [Spanish]
Itraconazole
Itraconazole & Bovine Lactoferrin
Itraconazole & Nyotran
Itraconazole & Nyotran(Liposomal Nystatin)
Itraconazole (JAN/USAN)
Itraconazole [USAN:BAN:INN:JAN]
Itraconazole oral solution
Itraconazolum
Itraconazolum [Latin]
Itrizole
Itrizole (TN)
Itrizole (tn)
LS-1843
MLS000028582
MLS000759472
MLS000863291
MLS001148245
MolPort-000-883-864
MolPort-003-848-295
NCGC00089812-03
Oriconazole
Oriconazole, R51211, Sporanox
Orungal
Prokanazol
R 51211
R-51211
S2476_Selleck
SAM001246679
SMR000058959
Sempera
Spherazole
Sporal
Sporanos
Sporanox
Sporanox (TN)
Sporanox (tn)
Sporonox
TL8005525
Triasporn
UNII-304NUG5GF4
cis-Itraconazole
itraconazole
17
EfinaconazoleapprovedPhase 42164650-44-6
Synonyms:
 
(2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
18
PolidocanolapprovedPhase 4249002-92-0
Synonyms:
Aethoxy-sklerol
Laureth 9
Laureth-9
Macrogol 9 lauryl ether
 
Nonaethylene glycol monododecyl ether
Nonaethylene glycol monolauryl ether
PEG-9 lauryl ether
Polydocanol
Polyethylene glycol 450 lauryl ether
Polyoxyl 9 lauryl ether
19tannic acidapproved, NutraceuticalPhase 4, Phase 31892
20
Docetaxelapproved, investigational, Approved May 1996Phase 4, Phase 31918114977-28-5148124, 9877265
Synonyms:
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate
(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
01885_FLUKA
114977-28-5
4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
AC-383
AC1L3WHJ
ANX-514
BIND-014
C11231
CHEBI:4672
CHEMBL92
CID148124
D07866
DB01248
Docetaxel
Docetaxel (INN)
Docetaxel anhydrous
Docetaxel, Trihydrate
EmDOC
 
HMS2089K08
InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5
MolPort-003-847-005
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-Boc-10-deacetyl taxol
NSC-628503
PSMA-targeted docetaxel nanoparticle
RP-56976
SDP-014
TXL
Taxotere
Taxotere (TN)
Taxotere(R)
XRP-6976L
docetaxel
docetaxel 114977-28-5
nchembio.188-comp8
nchembio.2007.34-comp7
nchembio.573-comp11
nchembio853-comp8
21Antirheumatic AgentsPhase 4, Phase 3, Phase 210627
22Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 112806
23Antifungal AgentsPhase 4, Phase 3, Phase 2, Phase 13615
24AmorolfinePhase 4, Phase 3, Phase 2, Phase 111
25DisinfectantsPhase 4547
26Dermatologic AgentsPhase 4, Phase 2, Phase 35674
27Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17793
28Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 122776
29Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112778
30Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 112770
31Antiparasitic AgentsPhase 4, Phase 3, Phase 22127
32Anti-Infective Agents, LocalPhase 41785
33Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 2, Phase 13822
34Steroid Synthesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 11718
35Keratolytic AgentsPhase 4, Phase 2, Phase 3420
36Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112767
37HormonesPhase 4, Phase 3, Phase 2, Phase 113979
38Adrenocorticotropic HormonePhase 4155
39beta-endorphinPhase 4133
40Cytochrome P-450 CYP2C9 InhibitorsPhase 4, Phase 2658
41Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 3, Phase 2, Phase 11666
42Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
43Chlorhexidine gluconatePhase 4472
44Melanocyte-Stimulating HormonesPhase 4132
45AnticonvulsantsPhase 4, Phase 3, Phase 22620
46Gastrointestinal AgentsPhase 4, Phase 38109
47Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 2, Phase 34295
48Adjuvants, ImmunologicPhase 42484
49HydroxyitraconazolePhase 4, Phase 3, Phase 2147
50Antimitotic AgentsPhase 4, Phase 35498

Interventional clinical trials:

(show top 50)    (show all 274)
idNameStatusNCT IDPhase
1Effectiveness of Lavage With Alcohol - Chlorhexidine for Chemical MatricectomyUnknown statusNCT01844141Phase 4
2Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic OnychomycosisUnknown statusNCT01014637Phase 4
3Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic ArthritisUnknown statusNCT01939132Phase 4
4Efficacy of Intraoperative Surgical Scrubbing in Reducing Bacterial Load After Nail Removal SurgeryCompletedNCT01330706Phase 4
5A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCompletedNCT01107756Phase 4
6Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic VarnishCompletedNCT02321098Phase 4
7Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%CompletedNCT02705664Phase 4
8Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail LacquerCompletedNCT02679911Phase 4
9Topical Penlac Nail Lacquer for Onychomycosis in ChildrenCompletedNCT01419847Phase 4
10A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis TreatmentCompletedNCT02464826Phase 4
11Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole CapsulesCompletedNCT00871728Phase 4
12Resin vs. Amorolfine vs. Terbinafine Treatment in OnychomycosisCompletedNCT01851590Phase 4
13Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric FracturesCompletedNCT00736684Phase 4
14Effects of Etanercept on Nail Psoriasis and Plaque PsoriasisCompletedNCT00581100Phase 4
15Evaluation of the Efficacy of Acitretin Therapy for Nail PsoriasisCompletedNCT00723437Phase 4
16A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque PsoriasisCompletedNCT01373567Phase 4
17A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific CountriesCompletedNCT01677598Phase 4
18Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or FeetCompletedNCT00735787Phase 4
19An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian FederationCompletedNCT01644396Phase 4
20Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte OnychomycosisRecruitingNCT02812043Phase 4
21Evaluation of the Efficacy of CURE-EX Treatment in OnychomycosisRecruitingNCT02436291Phase 4
22Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe OnychomycosisRecruitingNCT02812771Phase 4
23Treatment of Intertrochanteric Fracture With New Type of Intramedullary NailRecruitingNCT01437176Phase 4
24Outcome Comparison Between PFNA and InterTANRecruitingNCT01797237Phase 4
25A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic ArthritisRecruitingNCT02627768Phase 4
26An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset SeizuresRecruitingNCT01607346Phase 4
27Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP)Enrolling by invitationNCT02500758Phase 4
28An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail PsoriasisNot yet recruitingNCT03022617Phase 4
29An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid CystNot yet recruitingNCT02154789Phase 4
30TDT 067 Onychomycosis StudyUnknown statusNCT01145807Phase 3
31Treating OnychomychosisUnknown statusNCT00776464Phase 2, Phase 3
32Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and FemalesUnknown statusNCT00856596Phase 3
33Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
34Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.CompletedNCT00356915Phase 3
35Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big ToenailCompletedNCT00443820Phase 3
36Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big ToenailCompletedNCT00443898Phase 3
37Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail OnychomycosisCompletedNCT00459537Phase 3
38Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea PasteCompletedNCT00781820Phase 3
39Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01302119Phase 3
40Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01270971Phase 3
41PinPointe FootLaser for the Treatment of OnychomycosisCompletedNCT00935649Phase 2, Phase 3
42Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate OnychomycosisCompletedNCT01431820Phase 2, Phase 3
43Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With OnychomycosisCompletedNCT01008033Phase 3
44The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With OnychomycosisCompletedNCT01007708Phase 3
45Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic NailsCompletedNCT00999687Phase 2, Phase 3
46A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisCompletedNCT02016482Phase 3
47Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating PsoriasisCompletedNCT01445886Phase 2, Phase 3
48Treatment of Palmoplantar Psoriasis With Low Doses Interferential CurrentCompletedNCT01765985Phase 2, Phase 3
49Evaluation of a Low Fluoride Dentifrice for Caries ControlCompletedNCT01623362Phase 3
50A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01276639Phase 3

Search NIH Clinical Center for Nail Disease


Cochrane evidence based reviews: nail diseases

Genetic Tests for Nail Disease

About this section

Genetic tests related to Nail Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Nail26

Anatomical Context for Nail Disease

About this section

MalaCards organs/tissues related to Nail Disease:

35
Skin, Kidney, Bone, Lung, Liver, Heart, Testes

FMA organs/tissues related to Nail Disease:

17
Nail

Animal Models for Nail Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Nail Disease:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.8EGFR, FZD6, HRAS, KRAS, PLCD1

Publications for Nail Disease

About this section

Articles related to Nail Disease:

(show top 50)    (show all 53)
idTitleAuthorsYear
1
Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis. (27932277)
2016
2
Ultrasound in the management of nail disease. (26895940)
2015
3
Nail Disease for the Primary Care Provider. (26476249)
2015
4
Psoriatic nail disease, a predictor of psoriatic arthritis. (25409998)
2014
5
Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study. (23423871)
2013
6
Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. (24117389)
2013
7
Potential use of optical coherence tomography and high-frequency ultrasound for the assessment of nail disease in psoriasis and psoriatic arthritis. (23988587)
2013
8
Nail disease in psoriatic arthritis: distal phalangeal bone edema detected by magnetic resonance imaging predicts development of onycholysis and hyperkeratosis. (22337245)
2012
9
Assessment of psoriatic nail disease activity by rheumatologists: comment on the article by Lubrano et al. (22623218)
2012
10
Patient assessments of skin, joint, and nail disease activity in psoriatic arthritis. (22383354)
2012
11
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. (22156725)
2012
12
Optical coherence tomography: a new tool to assess nail disease in psoriasis? (21791896)
2011
13
Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index. (21174373)
2010
14
Nutrition and nail disease. (20620759)
2010
15
Psoriatic nail disease: quality of life and treatment. (19799826)
2009
16
Clinical practice. Fungal nail disease. (19439745)
2009
17
The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? (19424069)
2009
18
Management of psoriatic nail disease. (19341941)
2009
19
Nail disease in pemphigus vulgaris. (19903430)
2009
20
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. (18083272)
2008
21
Alefacept treatment of psoriatic nail disease: how severe should nail psoriasis be? (16546613)
2006
22
Therapies for psoriatic nail disease. A systematic review. (16724366)
2006
23
Alefacept in the treatment of psoriatic nail disease: a proof of concept study. (16673801)
2006
24
Alefacept in the treatment of psoriatic nail disease: a small case series. (15928640)
2005
25
Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. (18360572)
2005
26
Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked. (15113998)
2004
27
Molecular genetics of hereditary hair and nail disease. (15468149)
2004
28
One interpretation of a psychometric study of patients with nail disease. (12664041)
2003
29
Observer agreement in recording the clinical signs of nail disease and the accuracy of a clinical diagnosis of fungal and non-fungal nail disease. (12653750)
2003
30
Recurrence of fungal nail disease and the dissociation of relapse from re-infection. (11501665)
2001
31
Psoriatic arthritis, nail disease and pustules following Hodgkin's lymphoma. (10952760)
2000
32
Nail disease: antifungals have similar cure rates, different side-effects. (10570567)
1999
33
Manual of nail disease and surgery (9767626)
1998
34
Itraconazole now indicated to treat fungal nail disease. (11361668)
1996
35
Pediatric nail disease. (7742236)
1995
36
Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). (7496239)
1995
37
The differential diagnosis of nail disease. (11361432)
1995
38
Lamisil -- A New Measure in Antifungal Therapy in Skin and Nail Disease. Proceedings of a symposium. Vienna, Austria, 18 May 1993. (7910478)
1994
39
Epidemiology of fungal skin and nail disease: roundtable discussion held at Dermatology 2000, Vienna, 17 May 1993. (8186144)
1994
40
Oral therapeutic agents in fungal nail disease. (8077514)
1994
41
Candida onychomycosis--an evaluation of the candida species as primary keratinolytic yeasts in nail disease. (1381758)
1992
42
The spectrum of nail disease in patients with human immunodeficiency virus infection. (1619083)
1992
43
Nail disease. (2018711)
1991
44
A systematic approach to examining the patient with nail disease. (2650839)
1989
45
Nail disease and dermatology. (2681287)
1989
46
Hand, foot and nail disease--a common manifestation of chronic dermatophytosis. (3231234)
1988
47
Candida onychomycosis--an evaluation of the role of Candida species in nail disease. (3342176)
1988
48
Toe nail disease secondary to poorly fitting shoes or abnormal biomechanics. (4064760)
1985
49
THE ROLE OF PSEUDOMONAS AERUGINOSA IN NAIL DISEASE. (14043007)
1963
50
Base coat" nail disease. Report of a case. (14788850)
1950

Variations for Nail Disease

About this section

Clinvar genetic disease variations for Nail Disease:

5
id Gene Variation Type Significance SNP ID Assembly Location
1FZD6NM_003506.3(FZD6): c.1750G> T (p.Glu584Ter)SNVPathogenicrs151339002GRCh37Chr 8, 104342091: 104342091
2FZD6NM_003506.3(FZD6): c.1531C> T (p.Arg511Cys)SNVPathogenicrs151339003GRCh37Chr 8, 104340634: 104340634

Expression for genes affiliated with Nail Disease

About this section
Search GEO for disease gene expression data for Nail Disease.

Pathways for genes affiliated with Nail Disease

About this section

Pathways related to Nail Disease according to GeneCards Suite gene sharing:

(show all 47)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.8FZD6, RSPO4
29.4EGFR, HRAS
39.1EGFR, KRAS
49.1EGFR, KRAS
59.1HRAS, KRAS
69.1HRAS, KRAS
79.1HRAS, KRAS
89.1HRAS, KRAS
99.1HRAS, KRAS
10
Show member pathways
9.1HRAS, KRAS
11
Show member pathways
9.1EGFR, FZD6, HRAS
129.0EGFR, HRAS, PLCD1
138.8EGFR, FZD6, KRAS
148.8FZD6, HRAS, KRAS
158.8FZD6, HRAS, KRAS
168.8FZD6, HRAS, KRAS
178.7HRAS, KRAS, PLCD1
188.7HRAS, KRAS, PLCD1
198.6EGFR, HRAS, KRAS
208.6EGFR, HRAS, KRAS
21
Show member pathways
8.6EGFR, HRAS, KRAS
228.6EGFR, HRAS, KRAS
23
Show member pathways
8.6EGFR, HRAS, KRAS
24
Show member pathways
8.6EGFR, HRAS, KRAS
25
Show member pathways
8.6EGFR, HRAS, KRAS
26
Show member pathways
8.6EGFR, HRAS, KRAS
27
Show member pathways
8.6EGFR, HRAS, KRAS
28
Show member pathways
8.6EGFR, HRAS, KRAS
29
Show member pathways
8.6EGFR, HRAS, KRAS
308.6EGFR, HRAS, KRAS
31
Show member pathways
8.6EGFR, HRAS, KRAS
328.6EGFR, HRAS, KRAS
33
Show member pathways
8.6EGFR, HRAS, KRAS
34
Show member pathways
8.6EGFR, HRAS, KRAS
358.6EGFR, HRAS, KRAS
36
Show member pathways
8.6EGFR, HRAS, KRAS
378.3EGFR, FZD6, HRAS, KRAS
38
Show member pathways
8.3EGFR, FZD6, HRAS, KRAS
398.3EGFR, FZD6, HRAS, KRAS
40
Show member pathways
8.2EGFR, HRAS, KRAS, PLCD1
41
Show member pathways
8.2EGFR, HRAS, KRAS, PLCD1
428.2EGFR, HRAS, KRAS, PLCD1
43
Show member pathways
8.2EGFR, HRAS, KRAS, PLCD1
44
Show member pathways
8.2EGFR, HRAS, KRAS, PLCD1
45
Show member pathways
8.2EGFR, HRAS, KRAS, PLCD1
46
Show member pathways
7.8EGFR, FZD6, HRAS, KRAS, PLCD1
477.8EGFR, FZD6, HRAS, KRAS, PLCD1

GO Terms for genes affiliated with Nail Disease

About this section

Biological processes related to Nail Disease according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1hair follicle developmentGO:00019429.8EGFR, FZD6
2positive regulation of DNA replicationGO:00457409.7EGFR, HRAS
3social behaviorGO:00351769.1HRAS, KRAS
4ERBB2 signaling pathwayGO:00381288.9EGFR, HRAS, KRAS
5positive regulation of protein phosphorylationGO:00019348.9EGFR, HRAS, KRAS
6epidermal growth factor receptor signaling pathwayGO:00071738.9EGFR, HRAS, KRAS
7positive regulation of MAP kinase activityGO:00434068.8EGFR, HRAS, KRAS
8regulation of long-term neuronal synaptic plasticityGO:00481698.8HRAS, KRAS
9MAPK cascadeGO:00001658.7EGFR, HRAS, KRAS

Sources for Nail Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet